WordPress database error: [Table './aristoph_demo2/wp_blc_links' is marked as crashed and last (automatic?) repair failed]
FROM wp_blc_instances AS instances JOIN wp_blc_links AS links
ON instances.link_id = links.link_id
instances.container_type = 'page'
AND instances.container_id = 218
AND links.broken = 1
AND parser_type = 'link'
Research & Development
Our R&D department is located in Mandideep, Madhya Pradesh, which was established in the year 2003. The department is housed in a 12000 sq. ft. area comprising Formulation research & development and Analytical research & development section and recognized by the Department of Science & Technology, Government of India.
Marketing efforts of ARISTO are supported by a strong R&D team comprising highly qualified formulation and analytical scientists. It is fully equipped with state-of-the -art equipments, facilitating development of conventional and novel drug products complying to high standards of quality.
Our capabilities of drug product development are:
- Immediate Release Tablets
- Effervescent Tablets
- Orally Disintegrating Tablets
- Chewable Tablets
- Bilayered Tablets
- Inlay Tablets
- Delayed Release Tablets
- Extended Release Tablets
- Powder for Suspension / Syrups
- Oral Liquid Suspension / Syrups
- Hard Gelatin Capsules
- Multiple Unit Delayed Release / Extended Release Pellets (MUPS)
- Powder for Injection
- Liquid Injection
The analytical research & development section supports all the developmental work of formulation development. It is well equipped with highly sophisticated instruments and undertakes method development, stability studies, validation and method transfer.
Our research & development team have solved a number of complex challenges across oral solid, liquid, semi-solid dosage forms as well as parenterals – whether it is drug product complexity or drug substance complexity. We have the capability to deliver quality products within established timelines, at low costs without compromising on quality.
Although our drug products are developed adhering to Indian regulatory requirements and ICH guidelines; we consider the International regulatory agencies like USFDA in controlling the levels of inactive ingredients to be under IIG limits, following dissolution methods as per dissolution methods database for drug products. The drug substances are procured after detailed understanding of solubility and polymorphs to use in our formulations.